Dysregulation of BDNF and its main receptor, TrkB, has been documented in neurodegenerative disorders such as Parkinson's disease, Alzheimer's disease, and psychiatric diseases [27]. This evidence concerns the gene NTRK2 and early-onset autosomal dominant Alzheimer disease.